Moderna Stock Price To Sales
| M1RN34 Stock | BRL 12.10 0.05 0.41% |
Moderna fundamentals help investors to digest information that contributes to Moderna's financial success or failures. It also enables traders to predict the movement of Moderna Stock. The fundamental analysis module provides a way to measure Moderna's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Moderna stock.
Moderna |
Moderna Company Price To Sales Analysis
Moderna's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Moderna Price To Sales | 19.80 X |
Most of Moderna's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Moderna is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Moderna has a Price To Sales of 19.8023 times. This is 7.47% lower than that of the Healthcare sector and 79.88% lower than that of the Biotechnology industry. The price to sales for all Brazil stocks is 73.4% lower than that of the firm.
Moderna Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Moderna's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Moderna could also be used in its relative valuation, which is a method of valuing Moderna by comparing valuation metrics of similar companies.Moderna is rated below average in price to sales category among its peers.
Moderna Fundamentals
| Return On Equity | 0.84 | |||
| Return On Asset | 0.35 | |||
| Profit Margin | 0.55 % | |||
| Operating Margin | 0.62 % | |||
| Current Valuation | 387.59 B | |||
| Shares Outstanding | 7.68 B | |||
| Price To Book | 4.44 X | |||
| Price To Sales | 19.80 X | |||
| Revenue | 18.47 B | |||
| Gross Profit | 13.86 B | |||
| EBITDA | 13.54 B | |||
| Net Income | 12.2 B | |||
| Cash And Equivalents | 7.99 B | |||
| Cash Per Share | 19.80 X | |||
| Total Debt | 599 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 1.24 X | |||
| Book Value Per Share | 4.65 X | |||
| Cash Flow From Operations | 13.62 B | |||
| Earnings Per Share | 7.47 X | |||
| Number Of Employees | 3.7 K | |||
| Beta | 1.64 | |||
| Market Capitalization | 349.58 B | |||
| Total Asset | 24.67 B | |||
| Net Asset | 24.67 B |
About Moderna Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Moderna's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Moderna using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Moderna based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Moderna Stock
When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Moderna. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Moderna Stock refer to our How to Trade Moderna Stock guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.